BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 2524856)

  • 21. Facilitation of 8-OHDPAT-induced forepaw treading of rats by the 5-HT2 agonist DOI.
    Arnt J; Hyttel J
    Eur J Pharmacol; 1989 Feb; 161(1):45-51. PubMed ID: 2524390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin.
    Hoyer D; Engel G; Kalkman HO
    Eur J Pharmacol; 1985 Nov; 118(1-2):13-23. PubMed ID: 2935410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanistic studies on DOM as a discriminative stimulus.
    Glennon RA; Hauck AE
    Pharmacol Biochem Behav; 1985 Dec; 23(6):937-41. PubMed ID: 2934750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 5-HT1A and alpha-2 adrenergic receptors mediate the hyperglycemic and hypoinsulinemic effects of 8-hydroxy-2-(di-n-propylamino)tetralin in the conscious rat.
    Chaouloff F; Jeanrenaud B
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1159-66. PubMed ID: 2826757
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of 8-hydroxy-2-(di-n-propylamino)tetralin and other serotonergic agonists on performance in a radial maze: a possible role for 5-HT1A receptors in memory.
    Winter JC; Petti DT
    Pharmacol Biochem Behav; 1987 Aug; 27(4):625-8. PubMed ID: 2958885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mediation of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) by the putative 5-HT1A receptor.
    Tricklebank MD; Neill J; Kidd EJ; Fozard JR
    Eur J Pharmacol; 1987 Jan; 133(1):47-56. PubMed ID: 2881789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential effects of serotonin 5-HT1A receptor agonists on the discriminative stimulus effects of the 5-HT2A receptor agonist 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane in rats and rhesus monkeys.
    Li JX; Koek W; Rice KC; France CP
    J Pharmacol Exp Ther; 2010 Apr; 333(1):244-52. PubMed ID: 20053932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The enhancement by lithium of the 5-HT1A mediated serotonin syndrome produced by 8-OH-DPAT in the rat: evidence for a post-synaptic mechanism.
    Goodwin GM; De Souza RJ; Wood AJ; Green AR
    Psychopharmacology (Berl); 1986; 90(4):488-93. PubMed ID: 2949333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Release of endogenous aspartate from rat cerebellum slices and synaptosomes: inhibition mediated by a 5-HT2 receptor and by a 5-HT1 receptor of a possibly novel subtype.
    Maura G; Barzizza A; Folghera S; Raiteri M
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Mar; 343(3):229-36. PubMed ID: 1830929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurons in the hypothalamic paraventricular nucleus mediate the serotonergic stimulation of prolactin secretion via 5-HT1c/2 receptors.
    Rittenhouse PA; Levy AD; Li Q; Bethea CL; Van de Kar LD
    Endocrinology; 1993 Aug; 133(2):661-7. PubMed ID: 8344205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential effects of the new antipsychotic risperidone on sleep and wakefulness in the rat.
    Dugovic C; Wauquier A; Janssen PA
    Neuropharmacology; 1989 Dec; 28(12):1431-3. PubMed ID: 2482460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective activation of 5HT1A receptors induces lower lip retraction in the rat.
    Berendsen HH; Jenck F; Broekkamp CL
    Pharmacol Biochem Behav; 1989 Aug; 33(4):821-7. PubMed ID: 2533357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stimulus properties of tiflucarbine: a novel antidepressant agent.
    Glennon RA; De Vry J; Spencer DG; Glaser T
    Pharmacol Biochem Behav; 1990 Dec; 37(4):769-71. PubMed ID: 2151199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Behavioural profiles of putative 5-hydroxytryptamine receptor agonists and antagonists in developing rats.
    Jackson HC; Kitchen I
    Neuropharmacology; 1989 Jun; 28(6):635-42. PubMed ID: 2526930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological characterization of 8-OH-DPAT-induced inhibition of rat hippocampal 5-HT release in vivo as measured by microdialysis.
    Sharp T; Bramwell SR; Hjorth S; Grahame-Smith DG
    Br J Pharmacol; 1989 Nov; 98(3):989-97. PubMed ID: 2574066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of 5-HT1A- and alpha 2-receptors in the decreased 5-hydroxytryptamine release and metabolism in rat suprachiasmatic nucleus after intravenous 8-hydroxy-2-(n-dipropylamino) tetralin.
    Marsden CA; Martin KF
    Br J Pharmacol; 1986 Oct; 89(2):277-86. PubMed ID: 2430656
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Habituation of tactile startle is altered by drugs acting on serotonin-2 receptors.
    Geyer MA; Tapson GS
    Neuropsychopharmacology; 1988 May; 1(2):135-47. PubMed ID: 3150805
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stimulation of corticosterone secretion by the selective 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in the rat.
    Przegaliński E; Budziszewska B; Warchoł-Kania A; Błaszczyńska E
    Pharmacol Biochem Behav; 1989 Jun; 33(2):329-34. PubMed ID: 2530590
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serotonin receptors in the rat nucleus tractus solitarii and cardiovascular regulation.
    Shvaloff A; Laguzzi R
    Eur J Pharmacol; 1986 Dec; 132(2-3):283-8. PubMed ID: 3102261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological characterization of release-regulating serotonin autoreceptors in rat cerebellum.
    Bonanno G; Maura G; Raiteri M
    Eur J Pharmacol; 1986 Jul; 126(3):317-21. PubMed ID: 2944750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.